America’s plan to cut drug prices comes with unpleasant side-effects

economist.com “A piggy-bank of the pharma world,” gripes David Mitchell of Patients for Affordable Drugs, a consumer lobbying group. There is some truth to this. America is the world’s…

Bristol Myers Squibb Announces Perioperative Regimen of Neoadjuvant Opdivo (nivolumab) and Chemotherapy Followed by Adjuvant Opdivo Significantly Improves…

news.bms.com Bristol Myers Squibb (NYSE: BMY) today announced the Phase 3 CheckMate -77T trial met its primary endpoint of improved event-free survival (EFS) as assessed by Blinded…

The case for letting Medicare bureaucrats haggle with drug makers

reason.com When is a price control not a price control, extortion not extortion, and a tax not a tax? When drug manufacturers are fighting to preserve their government subsidies. No…

Big pharma can’t get enough of one class of cancer drugs

economist.com A world, dealmaking is in a rut. A combination of higher interest rates, geopolitical tensions and economic uncertainty has put a hold on joint ventures, mergers and…

Samsung Biologics adds to BMS manufacturing partnership with new $242M antibody agreement

fiercepharma.com After inking and expanding a biosimilar production partnership with Pfizer this summer, Korea’s Samsung Biologics is boosting yet another Big Pharma manufacturing agreement.…

Bristol Myers banks on 25-plus label expansions to help weather IRA, Revlimid generics and more

fiercepharma.com With the potential for more than two dozen label expansions on the horizon, Bristol Myers Squibb bets its pipeline can help it withstand the pressure from the Inflation…

BMS trims anti-TIGIT pipeline and a handful of other early- to-midstage meds

fiercebiotech.com As the TIGIT class gets closer to finally seeing clinical success, Bristol Myers Squibb is trimming one of its candidates. | As the TIGIT class gets closer to possible…

Is Pfizer Stock A Buy After The FDA Approved Its Updated Covid Shot?

investors.com The Food and Drug Administration signed off on Pfizer's (PFE) BioNTech (BNTX)-partnered Covid booster in mid-September, but Pfizer stock remains below its 50-day moving…

Eliquis for $55 a Month? That Is News to Us

wsj.com In “The High Cost of Price Controls on Eliquis and Other Drugs” (op-ed, Aug. 30), Giovanni Caforio of Bristol-Myers Squibb challenges the benefits of the Inflation Reduction…

Nick Leschly departs Bluebird Bio spinout amid restructuring, layoffs

statnews.com Some two years after splitting biotech company Bluebird Bio into two entities in a bid to “sharpen their focus” and improve operations, the spinout focused on oncology…

2seventy bio to lay off 40% of workforce; CEO to step down

aol.com 2seventy bio said on Tuesday it plans to lay off about 40% of its workforce to lower costs and focus on the biotech firm's cancer cell therapy Abecma, lifting the company's…